By writer to www.prnewswire.com
DENVER, Oct. 22, 2020 /PRNewswire/ — DaVita Scientific Analysis (DCR) will current 14 analysis abstracts from firm representatives and medical professionals on the American Society of Nephrology (ASN) annual Kidney Week occurring Oct. 22–25, 2020.
Amid the COVID-19 pandemic, ASN Kidney Week 2020 will convene greater than 13,000 kidney care professionals from all over the world in a digital format to debate developments within the discipline of nephrology.
“We imagine our dedication to pursuing life-enhancing analysis discoveries helps speed up transformation in kidney care,” stated Dr. Steven Brunelli, vp and medical director of well being economics and outcomes analysis for DCR. “Throughout these unprecedented occasions, Kidney Week continues to be a significant convening platform for scientific specialists to share significant insights and potential real-world options that might enhance the well-being of medically advanced kidney illness sufferers.”
DaVita researchers will report on findings from a number of retrospective research, with a specific give attention to how COVID-19 impacts dialysis sufferers, dwelling dialysis therapies and persistent kidney illness development.
This 12 months’s poster and presentation titles embody:
DaVita Scientific Analysis
- Evaluation of a Laboratory-Primarily based SARS-CoV-2 Antibody Take a look at Amongst Hemodialysis Sufferers: A High quality Enchancment Initiative
- Administration of Secondary Hyperparathyroidism Amongst Sufferers Who Transition from Each day At-Residence to 3X Weekly Oral Cinaclect Given In-Heart
- Associations Between Antimicrobial Barrier Cap Use and Outcomes Amongst Hemodialysis Sufferers Utilizing a Central Venous Catheter
- Pressing Begin Peritoneal Dialysis and Outcomes
- Longitudinal Evaluation of Random Variability in ICH-CAHPS Scores
- Use of Predictive Analytics to Inform Built-in Care Applications to Cut back Hospitalizations Amongst Hemodialysis Sufferers
- Exploration of Racial Disparities within the Kidney Transplant Course of Amongst Dialysis Sufferers
- Use of Incremental Peritoneal Dialysis: Affect on Scientific Outcomes and High quality-of-Life Measures
- Patterns of Hospital Admissions Amongst Sufferers with Continual Kidney Illness
- Growth and Validation of a Predictive Mannequin to Determine Sufferers with Undiagnosed Continual Kidney Illness
- Inpatient Dialysis Supplier Kind and Period of Hospital Admissions of Dialysis Sufferers
- Methods to Forestall An infection-Associated Losses in U.S. Peritoneal Dialysis Applications by Extra Actionable Predictive Knowledge Reporting
- Blood Strain Telemonitoring in Giant U.S. Peritoneal Dialysis Inhabitants
- Affect of the COVID-19 Pandemic on Digital Care in Residence Dialysis
ASN Kidney Week attendees can view ePosters and pre-recorded shows from DCR and DaVita Kidney Care scientific leaders at https://www.asn-online.org/kidneyweek/ starting Oct. 22. DaVita representatives shall be out there to debate applicable alternatives within the Kidney Week digital exhibit corridor. Dwell updates shall be shared all through the assembly on Twitter at @DaVitaDoc and @DaVitaResearch. Attendees, in addition to those that can’t take part within the digital periods, are inspired to affix or view the dialog by utilizing #KidneyWk.
To study extra about DCR, go to davitaclinicalresearch.com.
About DaVita Scientific Analysis
DaVita Scientific Analysis (DCR), an entirely owned subsidiary of DaVita Inc., is the analysis arm of DaVita. DCR innovates via retrospective analysis geared toward bettering scientific outcomes. DCR assists pharmaceutical and medical gadget firms within the design, recruitment and completion of scientific trials utilizing its renal analysis website community. To study extra about DCR, go to DaVitaClinicalResearch.com.
About DaVita Inc.
DaVita Inc. (NYSE: DVA) is a well being care supplier targeted on reworking care supply to enhance high quality of life for sufferers globally. The corporate is likely one of the largest suppliers of kidney care providers within the U.S. and has been a frontrunner in scientific high quality and innovation for greater than 20 years. By means of DaVita Kidney Care, the corporate treats sufferers with persistent kidney failure and finish stage kidney illness. DaVita is dedicated to daring, patient-centric care fashions, implementing the newest applied sciences and shifting towards built-in care choices for all. By means of these efforts, DaVita has additionally develop into the biggest supplier of dwelling dialysis within the nation. As of June 30, 2020, DaVita served 205,300 sufferers at 2,795 outpatient dialysis facilities in the United States and operated 287 outpatient dialysis facilities in ten international locations worldwide. DaVita has lowered hospitalizations, improved mortality, and labored collaboratively to propel the kidney care trade to undertake an equitable and high-quality commonplace of look after all sufferers, in all places. To study extra, go to DaVita.com/About.
SOURCE DaVita Scientific Analysis
— to www.prnewswire.com